15.67
price up icon1.36%   0.21
pre-market  시장 영업 전:  15.89   0.22   +1.40%
loading

Immunovant Inc (IMVT) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31
기간 3개월 3개월 3개월 3개월 3개월
Operating Expenses
9.92%
127.22
115.74 94.28 80.88 61.55
Income/Loss From Continuing Operations Before Tax
9.78%
-119.70
-109.04 -87.07 -75.09 -51.53
Income Tax Expense/Benefit
1,071%
0.913
0.078 0.077 0.232 -0.108
Income/Loss From Continuing Operations After Tax
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Net Income/Loss
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Diluted Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Basic Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Diluted Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$34.90
price down icon 2.43%
$81.66
price down icon 2.97%
$28.84
price down icon 2.07%
$98.08
price down icon 1.67%
$135.59
price down icon 3.84%
biotechnology ONC
$328.71
price down icon 0.34%
자본화:     |  볼륨(24시간):